192 related articles for article (PubMed ID: 16800854)
21. The evolving role of ankyrin-B in cardiovascular disease.
Koenig SN; Mohler PJ
Heart Rhythm; 2017 Dec; 14(12):1884-1889. PubMed ID: 28765088
[TBL] [Abstract][Full Text] [Related]
22. A Novel Mechanism for Human Cardiac Ankyrin-B Syndrome due to Reciprocal Chromosomal Translocation.
Huq AJ; Pertile MD; Davis AM; Landon H; James PA; Kline CF; Vohra J; Mohler PJ; Delatycki MB
Heart Lung Circ; 2017 Jun; 26(6):612-618. PubMed ID: 27916589
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms and Alterations of Cardiac Ion Channels Leading to Disease: Role of Ankyrin-B in Cardiac Function.
Sucharski HC; Dudley EK; Keith CBR; El Refaey M; Koenig SN; Mohler PJ
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32023981
[TBL] [Abstract][Full Text] [Related]
24. Common human ANK2 variant confers in vivo arrhythmia phenotypes.
Musa H; Murphy NP; Curran J; Higgins JD; Webb TR; Makara MA; Wright P; Lancione PJ; Lubbers ER; Healy JA; Smith SA; Bennett V; Hund TJ; Kline CF; Mohler PJ
Heart Rhythm; 2016 Sep; 13(9):1932-40. PubMed ID: 27298202
[TBL] [Abstract][Full Text] [Related]
25. Dysfunction in the βII spectrin-dependent cytoskeleton underlies human arrhythmia.
Smith SA; Sturm AC; Curran J; Kline CF; Little SC; Bonilla IM; Long VP; Makara M; Polina I; Hughes LD; Webb TR; Wei Z; Wright P; Voigt N; Bhakta D; Spoonamore KG; Zhang C; Weiss R; Binkley PF; Janssen PM; Kilic A; Higgins RS; Sun M; Ma J; Dobrev D; Zhang M; Carnes CA; Vatta M; Rasband MN; Hund TJ; Mohler PJ
Circulation; 2015 Feb; 131(8):695-708. PubMed ID: 25632041
[TBL] [Abstract][Full Text] [Related]
26. Cardiac channelopathies.
Marbán E
Nature; 2002 Jan; 415(6868):213-8. PubMed ID: 11805845
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility genes and modifiers for cardiac arrhythmias.
Kääb S; Schulze-Bahr E
Cardiovasc Res; 2005 Aug; 67(3):397-413. PubMed ID: 15949790
[TBL] [Abstract][Full Text] [Related]
28. The role of microRNA in cardiac excitability.
Wang Z
J Cardiovasc Pharmacol; 2010 Nov; 56(5):460-70. PubMed ID: 20588186
[TBL] [Abstract][Full Text] [Related]
29. Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease.
Cunha SR; Le Scouarnec S; Schott JJ; Mohler PJ
J Mol Cell Cardiol; 2008 Dec; 45(6):724-34. PubMed ID: 18790697
[TBL] [Abstract][Full Text] [Related]
30. Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.
Ackerman MJ; Mohler PJ
Circ Res; 2010 Aug; 107(4):457-65. PubMed ID: 20724725
[TBL] [Abstract][Full Text] [Related]
31. Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.
Mohler PJ; Le Scouarnec S; Denjoy I; Lowe JS; Guicheney P; Caron L; Driskell IM; Schott JJ; Norris K; Leenhardt A; Kim RB; Escande D; Roden DM
Circulation; 2007 Jan; 115(4):432-41. PubMed ID: 17242276
[TBL] [Abstract][Full Text] [Related]
32. Rare Variants in ANK2 Associated With Various Inherited Arrhythmia Syndromes.
Watanabe H; Minamino T
Circ J; 2016 Nov; 80(12):2423-2424. PubMed ID: 27818464
[No Abstract] [Full Text] [Related]
33. Familial Wolff-Parkinson-White Syndrome: a disease of glycogen storage or ion channel dysfunction?
Light PE
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S158-S161. PubMed ID: 16686673
[TBL] [Abstract][Full Text] [Related]
34. Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation.
Cunha SR; Hund TJ; Hashemi S; Voigt N; Li N; Wright P; Koval O; Li J; Gudmundsson H; Gumina RJ; Karck M; Schott JJ; Probst V; Le Marec H; Anderson ME; Dobrev D; Wehrens XH; Mohler PJ
Circulation; 2011 Sep; 124(11):1212-22. PubMed ID: 21859974
[TBL] [Abstract][Full Text] [Related]
35. Dysfunction in ankyrin-based cellular pathways and human cardiac arrhythmia.
Mohler PJ; Lowe JS; Banks S
Future Cardiol; 2005 May; 1(3):363-71. PubMed ID: 19804119
[TBL] [Abstract][Full Text] [Related]
36. Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview.
Smits JP; Blom MT; Wilde AA; Tan HL
Expert Opin Pharmacother; 2008 Mar; 9(4):537-49. PubMed ID: 18312156
[TBL] [Abstract][Full Text] [Related]
37. The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why?
Scicluna BP; Wilde AA; Bezzina CR
J Cardiovasc Electrophysiol; 2008 Apr; 19(4):445-52. PubMed ID: 18284507
[TBL] [Abstract][Full Text] [Related]
38. Ankyrins and Spectrins in Cardiovascular Biology and Disease.
El Refaey MM; Mohler PJ
Front Physiol; 2017; 8():852. PubMed ID: 29163198
[TBL] [Abstract][Full Text] [Related]
39. Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization.
Rivard K; Paradis P; Nemer M; Fiset C
Cardiovasc Res; 2008 Apr; 78(1):53-62. PubMed ID: 18245065
[TBL] [Abstract][Full Text] [Related]
40. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.
Mohler PJ; Rivolta I; Napolitano C; LeMaillet G; Lambert S; Priori SG; Bennett V
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17533-8. PubMed ID: 15579534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
